Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
DIFFERIN 0.1% CREAM 30G
- Sku : I-001673
Key features
DIFFERIN 0.1% Cream is a topical cream containing the active ingredient adapalene 0.1%. It selectively binds retinoic acid receptors (primarily RAR-β and RAR-γ) to normalize follicular epithelial differentiation and keratinization, reducing microcomedone formation and inflammation. It is indicated for the topical treatment of acne vulgaris. Supplied as a prescription topical cream in a 30 g tube.- Brand: DIFFERIN
- Active Ingredient: ADAPALENE 0.1%
- Strength: 0.1%
- Dosage Form: Cream
- Pack Size: 30 g
- Route: Topical
- Prescription Status: Prescription
- Therapeutic Class: Dermatological
- Pharmacological Group: Anti-acne Preparations
- Drug Class: Topical retinoid (third-generation synthetic retinoid); anti-acne preparation (ATC D10AD03).
- Manufacturer: GALDERMA
- Country of Origin: France
- SFDA Registration No.: 3004257321
- Shelf Life: 36 months
- Storage: store below 25°c
- Skin Condition: Acne
Frequently bought together
Indications
Approved Uses
Acne vulgaris.
Dosage & Administration
Dosing by Condition
Acne vulgaris: apply a thin film to affected area(s) once daily in the evening after washing and drying; initial and maintenance dosing are the same, adjusted only for tolerability.
Initial Dose
Apply a thin film to affected areas once daily in the evening.
Maintenance Dose
Apply a thin film to affected areas once daily in the evening.
Maximum Dose
Apply a thin film once daily (typically at night) to affected areas; no systemic maximum dose is established for topical use.
Children's Dosage
Not approved for children under 12 years; for adolescents 12 years and older: same as adult dosing (once daily topical application)
Dose Adjustment Notes
No renal/hepatic dose adjustment is required due to minimal systemic absorption; if excessive local irritation occurs, reduce frequency (e.g., every other day) or temporarily discontinue until tolerated.
How to Take
Cleanse gently and dry the skin; apply a thin film (e.g., pea-sized amount for the whole face) to the affected area(s) once daily in the evening; avoid eyes, lips, nostrils, and mucous membranes; wash hands after application.
Side Effects
Common Side Effects
Erythema, dryness, scaling, burning, stinging, pruritus at application site, skin irritation
Side Effect Frequency
Very common (>10%): application-site dryness, erythema, scaling/desquamation, burning/stinging/irritation. Common (1-10%): pruritus, skin discomfort, sunburn. Uncommon (<1%): contact dermatitis/eczema, eyelid edema, conjunctivitis, rash/skin discoloration, acne flare.
Safety & Warnings
Contraindications
Hypersensitivity to adapalene or any excipients.
Warnings & Precautions
For external use only; avoid contact with eyes, lips, mucous membranes and angles of the nose. Do not apply to cuts/abrasions, eczematous, sunburned, windburned, or otherwise irritated skin. Minimize sun/UV exposure (including sunlamps) and use sunscreen/protective clothing. Expect local irritation early; reduce frequency or discontinue if severe. Avoid waxing/depilatories on treated areas and use caution with other irritating topical products.
Age Restriction
Not approved under 12 years.
Driving Warning
Safe
Drug Interactions
Drug Interactions
No clinically significant systemic drug-drug interactions are expected with topical adapalene; avoid or use caution with concurrent topical products that increase irritation (e.g., other retinoids, benzoyl peroxide, sulfur/resorcinol/salicylic acid, medicated/abrasive cleansers, astringents, high-alcohol products).
Interaction Severity
MODERATE: concomitant use with other irritating/drying topical agents (e.g., benzoyl peroxide, salicylic acid, sulfur/resorcinol, abrasive cleansers, astringents/high-alcohol products) may increase irritation; no routine 'major' drug-drug interactions are expected for topical adapalene-use caution with other photosensitizing procedures/agents and emphasize photoprotection.
Food Interaction
No restriction
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Caution
Children
Not approved for children under 12 years; for adolescents 12 years and older: same as adult dosing (once daily topical application)
Elderly
Standard adult dosing; no specific adjustments required
Kidney Impairment
No adjustment needed.
Liver Impairment
No adjustment needed.
Storage & Patient Advice
Stopping the Medicine
Can be stopped at any time; no taper is required. Acne may recur after discontinuation.
Overdose
Topical overuse may cause marked local irritation (erythema, peeling, burning/discomfort); manage with supportive skin care and reduce frequency or discontinue until tolerated. Accidental ingestion is unlikely to be life-threatening but warrants medical advice/poison center contact; large/chronic ingestion could cause retinoid (vitamin A-like) toxicity symptoms.
Patient Counseling
Use once nightly on clean, dry skin in a thin layer; expect dryness/peeling and possible early flare in the first weeks; use moisturizer and daily sunscreen/limit sun exposure; avoid eyes/lips/mucosa and avoid applying to broken, sunburned, or eczematous skin; reduce frequency or pause if significant irritation occurs; results usually take 8-12 weeks or longer.
Monitoring Requirements
No routine laboratory monitoring; monitor clinically for efficacy and local tolerability (erythema, dryness, peeling, burning) and adherence.
Pharmacology
Mechanism of Action
Adapalene selectively binds retinoic acid receptors (primarily RAR-β and RAR-γ), modulating gene expression to normalize follicular epithelial differentiation/keratinization, reduce microcomedone formation, and exert anti-inflammatory effects.
Onset of Action
Improvement is typically seen after about 8-12 weeks; maximal benefit may take several months with continued use.
Duration of Effect
Benefit is maintained only with continued use; acne commonly recurs after discontinuation.
Half-Life
Unknown/not well characterized with topical use due to minimal systemic absorption.
Bioavailability
Minimal systemic absorption after topical application; systemic bioavailability is very low/negligible.
Excretion
Primarily biliary excretion with elimination mainly in feces (biliary/fecal) for any absorbed fraction.
Product Information
Available Dosage Forms
Cream
Composition per Dose
Each gram of cream: 1 mg adapalene (0.1%) in a cream base
Generic Availability
Yes
Skin Condition
Acne
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)














